Product Details
// Quality First, Safety Guaranteed.
Retatrutide
Peptides
Retatrutide
Basic Info.
Retatrutide is an experimental drug developed by Eli Lilly and Company in the United States for the treatment of obesity. It is a triple glucagon hormone receptor agonist.
In a phase II clinical trial, the drug has been proved to reduce the average weight of non diabetes but obese or pre obese (overweight) adults by more than 17.5%
Areas of Expertise
-
Leading-Edge Manufacturing Capabilityg
-
Advanced R&D and State-of-the-Art Facilities
-
Versatile and Scalable Packaging Solutions
-
Certified Quality & International Compliance
English